Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas

Muhammad Wasif Saif; H Oettle; W L. Vervenne; J P. Thomas; G Spitzer; C Visseren-Grul; N Enas; D A. Richards

doi:10.1097/ppo.0b013e3181b36264

Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas

The Cancer Journal ◽

10.1097/ppo.0b013e3181b36264 ◽

2009 ◽

Vol 15 (4) ◽

pp. 339-343 ◽

Cited By ~ 33

Author(s):

Muhammad Wasif Saif ◽

H Oettle ◽

W L. Vervenne ◽

J P. Thomas ◽

G Spitzer ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

Adenocarcinoma Of The Pancreas

Download Full-text

Randomized double-blind phase II trial comparing gemcitabine (GEM) plus LY293111 vs. GEM plus placebo in advanced adenocarcinoma of the pancreas

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4092 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4092-4092 ◽

Cited By ~ 3

Author(s):

D. A. Richards ◽

H. Oettle ◽

W. L. Vervenne ◽

M. W. Saif ◽

J. P. Thomas ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

Adenocarcinoma Of The Pancreas

Download Full-text

265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.259 ◽

2020 ◽

Vol 31 ◽

pp. S1347

Author(s):

Y. Chi ◽

M. Gao ◽

Y. Zhang ◽

F. Shi ◽

Y. Cheng ◽

...

Keyword(s):

Thyroid Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Differentiated Thyroid Carcinoma ◽

Double Blind ◽

Multicenter Phase

Download Full-text

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)

European Journal of Cancer ◽

10.1016/j.ejca.2015.10.012 ◽

2016 ◽

Vol 53 ◽

pp. 144-154 ◽

Cited By ~ 19

Author(s):

Konstantinos Tryfonidis ◽

Gul Basaran ◽

Jan Bogaerts ◽

Marc Debled ◽

Luc Dirix ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

European Organisation ◽

Hormone Receptor Positive

Download Full-text

Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study

Journal of Stroke and Cerebrovascular Diseases ◽

10.1016/j.jstrokecerebrovasdis.2021.105761 ◽

2021 ◽

Vol 30 (6) ◽

pp. 105761

Author(s):

Takeshi Yoshimoto ◽

Satoshi Saito ◽

Katsuhiro Omae ◽

Yorito Hattori ◽

Kazuki Fukuma ◽

...

Keyword(s):

Ischemic Stroke ◽

Phase Ii ◽

Study Protocol ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Stroke Study

Download Full-text

A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas

Cancer ◽

10.1002/1097-0142(19921001)70:7<1864::aid-cncr2820700709>3.0.co;2-d ◽

1992 ◽

Vol 70 (7) ◽

pp. 1864-1866 ◽

Cited By ~ 27

Author(s):

Werner Scheithauer ◽

Franz Pfeffel ◽

Gabriela Kornek ◽

Arthur Marczell ◽

Christoph Wiltschke ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Adenocarcinoma Of The Pancreas

Download Full-text

P1 Circulating adiponectin levels as a predictive factor of breast cancer in a double-blind 2×2 phase II trial of low-dose tamoxifen and fenretinide for breast cancer prevention

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70759-x ◽

2010 ◽

Vol 8 (2) ◽

pp. 9

Author(s):

A. Guerrieri Gonzaga ◽

S. Gandini ◽

H. Johansson ◽

D. Macis ◽

P. Magni ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Prevention ◽

Phase Ii ◽

Predictive Factor ◽

Low Dose ◽

Phase Ii Trial ◽

Breast Cancer Prevention ◽

Double Blind

Download Full-text

A randomized double-blind phase II trial evaluating maintenance PARP inhibitor Olaparib versus placebo in patients with platinum-sensitive advanced non-small cell lung cancer: PIPSeN trial

Annals of Oncology ◽

10.1093/annonc/mdx380.082 ◽

2017 ◽

Vol 28 ◽

pp. v494

Author(s):

S. Postel-Vinay ◽

D. Planchard ◽

A.L. Ortega Granados ◽

A. Gazzah ◽

M.A. Sala Gonzalez ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Parp Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Platinum Sensitive

Download Full-text

P-255 A randomized, placebo-controlled, double-blind phase II trial of peri-operative cimetidine in early colorectal cancer

Annals of Oncology ◽

10.1093/annonc/mdv233.252 ◽

2015 ◽

Vol 26 ◽

pp. iv74

Author(s):

M. Jameson ◽

M. Arendse ◽

M. Findlay ◽

I. Bissett ◽

S. Lolohea ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Early Colorectal Cancer ◽

Double Blind

Download Full-text

Phase II trial of gemcitabine (2,2?-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Investigational New Drugs ◽

10.1007/bf00873232 ◽

1994 ◽

Vol 12 (1) ◽

pp. 29-34 ◽

Cited By ~ 296

Author(s):

Ephraim S. Casper ◽

Mark R. Green ◽

David P. Kelsen ◽

Robert T. Heelan ◽

Thomas D. Brown ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Adenocarcinoma Of The Pancreas

Download Full-text

Efficacy and safety of the noradrenaline reuptake inhibitor, TAS‐303, in women with stress urinary incontinence: Results of a double‐blind, randomized, placebo‐controlled, early phase II trial

International Journal of Urology ◽

10.1111/iju.14411 ◽

2020 ◽

Author(s):

Satoru Takahashi ◽

Kumiko Kato ◽

Mineo Takei ◽

Osamu Yokoyama ◽

Momokazu Gotoh

Keyword(s):

Urinary Incontinence ◽

Stress Urinary Incontinence ◽

Phase Ii ◽

Reuptake Inhibitor ◽

Early Phase ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Noradrenaline Reuptake ◽

Noradrenaline Reuptake Inhibitor

Download Full-text